Dan Wright

Associate Professor Dan Wright is a clinical pharmacology expert at the Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney. He holds a pharmacy degree from Dalhousie University, an MSc in Clinical Pharmacology, and a PhD from the University of Otago. His work focuses on medication adherence, population pharmacokinetics, and precision dosing, with extensive experience in hospital pharmacy practice.

Education:

• B Pharm (Dalhousie University)
• MSc in Clinical Pharmacology (University of Otago)
• PhD (University of Otago)

Research Interests: Medication adherence impact on outcomes, population pharmacokinetic modeling, model-informed dosing, therapeutic drug monitoring, and renal drug dosing. His work emphasizes translating pharmacometric insights into clinical practice to improve patient outcomes in chronic conditions like gout.

Articles Trends: Recent publications highlight advancements in allopurinol dosing algorithms for gout, adherence measurement tools, and pharmacogenomic factors influencing drug response. His work often bridges clinical research with practical guidelines for optimizing medication therapy.

Awards:

• Repeated School of Pharmacy Best Lecturer Award (2019–2023)
• Emerging Researcher Award (2018)
• Top Editor Prize (BJCP, 2018–2019)

Advising/Grants: Lead the FMH Start-up Scheme grant (2024) for clinical pharmacology projects. Active in mentoring editorial boards (e.g., British Journal of Clinical Pharmacology) and professional societies like ASCEPT.

Labs/Teams: Leads the Easy-Allo Study team for gout dosing innovation and chairs ASCEPT's environmental sustainability portfolio. Collaborates internationally on pharmacometric and adherence research initiatives.